EUVIMEDUpptäck EUVIMED
Open access · CC BY 4.0

Risk Factors and Clinical Outcomes of Invasive Fungal Infections in Patients with Severe COVID-19: A Case–Control Study

Nosheen Nasir, Syed Abbas Moazzam Kazmi iD, Joveria Farooqi iD, Muhammad Irfan iD, Kauser Jabeen iD

Pathogens · 2025

DOI: 10.3390/pathogens14101064 ↗

At a glance

Journal article in Pathogens, 2025. Written by Nosheen Nasir and 4 co-authors. Institution: Department of Medicine, Aga Khan University, Karachi 74800, Pakistan. Major MEDLINE topics: COVID-19, Invasive Fungal Infections. 45 references. The full text is freely available (open access, CC BY 4.0). Funded by: CDC HHS, Centers for Disease Control and Prevention, PTE Federal.

AbstractSubjectsBibliografiska uppgifterCiteRelated studies

Abstract (original language)

Background

Invasive fungal infections (IFIs) in patients with COVID-19 contribute to significant morbidity and mortality, with reported incidence between 5% and 26.7%. COVID-19-associated pulmonary aspergillosis (CAPA), candidiasis (CAC), mucormycosis (CAM), and Pneumocystis jirovecii pneumonia (PJP) are the most common IFIs in this population. Methodology: We conducted a case–control study in the ratio of 1:2 between March 2020 and April 2022 using institutional COVID-19 registry data. The cases were severe COVID-19 patients with IFIs, and the controls were severe COVID-19 patients without IFIs. Multivariate logistic regression was used to identify independent risk factors, with adjusted odds ratios (aOR) and 95% confidence intervals (CIs). The outcomes for the study were to assess the clinical outcomes, i.e., in-hospital mortality and length of hospitalization in a subgroup of severe COVID-19 patients who had IFIs. A p-value < 0.05 was considered significant.

Results

Among 5368 COVID-19 patients admitted to hospital during the study period, 1333 had a severe infection. Of these, 158/1333 (11.8%) met the criteria for IFIs, with a median age of 65 years and 71% male predominance. Diabetes (53.8%) and hypertension (57.6%) were the most common comorbid conditions. Acute respiratory distress syndrome (ARDS) developed in 55% of patients. Overall mortality was 48%. For the case control analysis, 119 patients with IFIs were selected as cases and 240 patients without IFIs were selected as controls. On univariate analysis ARDS was significantly associated with IFIs (OR: 1.91; 95% CI: 1.23–2.99, p-value = 0.004). Patients with IFIs had higher odds of being on hemodialysis compared to those without IFIs (OR: 2.17; 95% CI: 1.18–3.99; p-value = 0.013). Mechanical ventilation was found to be independently associated with IFIs in multivariate logistic regression analysis (OR: 2.5, 95% CI: 1.58–3.96, p-value < 0.001). The odds for in-hospital death in patients with IFIs were 2.19 (95% CI: 1.35–3.56; p-value < 0.001) compared to patients without IFIs. The median hospital stay for patients with IFIs was markedly longer (14 days) compared to 8 days in patients without IFIs.

Conclusions

IFIs significantly worsened outcomes in severe COVID-19 patients, leading to increased mortality and prolonged hospital stays. Mechanical ventilation was an independent risk factor for IFIs.

Subjects

MeSH terms (MEDLINE)

COVID-19Invasive Fungal InfectionsHumansMaleCase-Control StudiesFemaleRisk FactorsMiddle AgedAgedHospital MortalitySARS-CoV-2Length of StayMucormycosisAdultAged, 80 and over

Author keywords

COVID-19-associated invasive fungal infectionsICU mortalityaspergillosiscandidiasisinvasive fungal infection (IFIs)invasive mechanical ventilationsevere COVID-19

Authors and institutions

  • Department of Medicine, Aga Khan University, Karachi 74800, Pakistan.
  • Medical College, Aga Khan University, Karachi 74800, Pakistan.
  • Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi 74800, Pakistan.

ORCID profiles: Syed Abbas Moazzam Kazmi, Joveria Farooqi, Muhammad Irfan, Kauser Jabeen

Funding

  • CDC HHS
  • Centers for Disease Control and Prevention
  • PTE Federal

Cite

APA

Nasir, N., Kazmi, S. A. M., Farooqi, J., Irfan, M., & Jabeen, K. (2025). Risk Factors and Clinical Outcomes of Invasive Fungal Infections in Patients with Severe COVID-19: A Case–Control Study. Pathogens. https://doi.org/10.3390/pathogens14101064

Vancouver

Nasir N, Kazmi SAM, Farooqi J, Irfan M, Jabeen K. Risk Factors and Clinical Outcomes of Invasive Fungal Infections in Patients with Severe COVID-19: A Case–Control Study. Pathogens. 2025. doi:10.3390/pathogens14101064

BibTeX
@article{Nasir2025,
  author = {Nasir, Nosheen and Kazmi, Syed Abbas Moazzam and Farooqi, Joveria and Irfan, Muhammad and Jabeen, Kauser},
  title = {Risk Factors and Clinical Outcomes of Invasive Fungal Infections in Patients with Severe COVID-19: A Case–Control Study},
  journal = {Pathogens},
  year = {2025},
  doi = {10.3390/pathogens14101064}
}
Start for free →